Evidence map›Paper›PMID 28803334›Full record

ReviewLangenbeck's archives of surgery2017

Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum.

Andrew M Brown, Danica N Giugliano, Adam C Berger, Michael J Pucci, Francesco Palazzo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Langenbeck's archives of surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Current surgical treatment of esophagogastric junction adenocarcinoma.World journal of gastrointestinal oncology · 2019
    Review
  17. Article
  18. RISK FACTORS FOR SEVERE POSTOPERATIVE COMPLICATIONS AFTER GASTRECTOMY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION CANCERS.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2019
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrew M BrownDepartment of Surgery, Thomas Jefferson University Hospital, 1100 Walnut St. 5th Floor, Philadelphia, PA, 19107, USA.
Danica N GiuglianoDepartment of Surgery, Thomas Jefferson University Hospital, 1100 Walnut St. 5th Floor, Philadelphia, PA, 19107, USA.
Adam C BergerDepartment of Surgery, Thomas Jefferson University Hospital, 1100 Walnut St. 5th Floor, Philadelphia, PA, 19107, USA.
Michael J PucciDepartment of Surgery, Thomas Jefferson University Hospital, 1100 Walnut St. 5th Floor, Philadelphia, PA, 19107, USA.
Francesco PalazzoDepartment of Surgery, Thomas Jefferson University Hospital, 1100 Walnut St. 5th Floor, Philadelphia, PA, 19107, USA. Francesco.Palazzo@jefferson.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Siewert classification system for gastroesophageal junction adenocarcinoma has provided morphological and topographical information to help guide surgical decision-making. Evidence has shown that Siewert I and III tumors are distinct entities with differing epidemiologic and histologic characteristics and distinct patterns of disease progression, requiring different treatment. Siewert II tumors share some of the characteristics of type I and III lesions, and the surgical approach is not universally agreed upon. Appropriate surgical options include transthoracic esophagogastrectomy, transhiatal esophagectomy, and transabdominal extended total gastrectomy. PURPOSE: A review of the available evidence of the surgical management of Siewert II tumors is presented.

conclusionsCareful review of the data appear to support the fact that a satisfactory oncologic resection can be achieved via a transabdominal extended total gastrectomy with a slight advantage in terms of perioperative complications, and overall postoperative quality of life. Overall and disease-free survival compares favorably to the transthoracic approach. These results can be achieved with careful selection of patients balancing more than just the Siewert type in the decision-making but considering also preoperative T and N stages, histological type (diffuse type requiring longer margins that are not always achievable via gastrectomy), and the presence of Barrett's esophagus.

Indexed as

EsophagectomyEsophagogastric JunctionGastrectomyAdenocarcinomaFemaleHumansMaleStomach NeoplasmsEsophagectomyGastrectomyGastroesophageal junction adenocarcinomaSiewert classification

Identifiers

PMID28803334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.